Global Hematological Malignancies Market Size, Status and Forecast 2018-2025
- QYR2769100
- 90 Pages
- September 2018
- Medical Devices
Hematologic malignancies are forms of cancer that begin in the cells of blood-forming tissue, such as the bone marrow, or in the cells of the immune system.
In 2017, the global Hematological Malignancies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
The key players covered in this study
AbbVie
Bristol-Myers Squibb
Celgene
Roche
GlaxoSmithKline
Johnson & Johnson
Novartis
Pfizer
Teva Pharmaceutical
Market segment by Type, the product can be split into
Leukemia
Lymphoma
Myeloma
Market segment by Application, split into
Hospital Pharmacies
Medical Stores
E-commerce Platform
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Hematological Malignancies status, future forecast, growth opportunity, key market and key players.
To present the Hematological Malignancies development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Hematological Malignancies are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hematological Malignancies Market Size Growth Rate by Type (2013-2025)
1.4.2 Leukemia
1.4.3 Lymphoma
1.4.4 Myeloma
1.5 Market by Application
1.5.1 Global Hematological Malignancies Market Share by Application (2013-2025)
1.5.2 Hospital Pharmacies
1.5.3 Medical Stores
1.5.4 E-commerce Platform
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Hematological Malignancies Market Size
2.2 Hematological Malignancies Growth Trends by Regions
2.2.1 Hematological Malignancies Market Size by Regions (2013-2025)
2.2.2 Hematological Malignancies Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Hematological Malignancies Market Size by Manufacturers
3.1.1 Global Hematological Malignancies Revenue by Manufacturers (2013-2018)
3.1.2 Global Hematological Malignancies Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Hematological Malignancies Market Concentration Ratio (CR5 and HHI)
3.2 Hematological Malignancies Key Players Head office and Area Served
3.3 Key Players Hematological Malignancies Product/Solution/Service
3.4 Date of Enter into Hematological Malignancies Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Hematological Malignancies Market Size by Type (2013-2018)
4.2 Global Hematological Malignancies Market Size by Application (2013-2018)
5 United States
5.1 United States Hematological Malignancies Market Size (2013-2018)
5.2 Hematological Malignancies Key Players in United States
5.3 United States Hematological Malignancies Market Size by Type
5.4 United States Hematological Malignancies Market Size by Application
6 Europe
6.1 Europe Hematological Malignancies Market Size (2013-2018)
6.2 Hematological Malignancies Key Players in Europe
6.3 Europe Hematological Malignancies Market Size by Type
6.4 Europe Hematological Malignancies Market Size by Application
7 China
7.1 China Hematological Malignancies Market Size (2013-2018)
7.2 Hematological Malignancies Key Players in China
7.3 China Hematological Malignancies Market Size by Type
7.4 China Hematological Malignancies Market Size by Application
8 Japan
8.1 Japan Hematological Malignancies Market Size (2013-2018)
8.2 Hematological Malignancies Key Players in Japan
8.3 Japan Hematological Malignancies Market Size by Type
8.4 Japan Hematological Malignancies Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Hematological Malignancies Market Size (2013-2018)
9.2 Hematological Malignancies Key Players in Southeast Asia
9.3 Southeast Asia Hematological Malignancies Market Size by Type
9.4 Southeast Asia Hematological Malignancies Market Size by Application
10 India
10.1 India Hematological Malignancies Market Size (2013-2018)
10.2 Hematological Malignancies Key Players in India
10.3 India Hematological Malignancies Market Size by Type
10.4 India Hematological Malignancies Market Size by Application
11 Central & South America
11.1 Central & South America Hematological Malignancies Market Size (2013-2018)
11.2 Hematological Malignancies Key Players in Central & South America
11.3 Central & South America Hematological Malignancies Market Size by Type
11.4 Central & South America Hematological Malignancies Market Size by Application
12 International Players Profiles
12.1 AbbVie
12.1.1 AbbVie Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hematological Malignancies Introduction
12.1.4 AbbVie Revenue in Hematological Malignancies Business (2013-2018)
12.1.5 AbbVie Recent Development
12.2 Bristol-Myers Squibb
12.2.1 Bristol-Myers Squibb Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hematological Malignancies Introduction
12.2.4 Bristol-Myers Squibb Revenue in Hematological Malignancies Business (2013-2018)
12.2.5 Bristol-Myers Squibb Recent Development
12.3 Celgene
12.3.1 Celgene Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hematological Malignancies Introduction
12.3.4 Celgene Revenue in Hematological Malignancies Business (2013-2018)
12.3.5 Celgene Recent Development
12.4 Roche
12.4.1 Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hematological Malignancies Introduction
12.4.4 Roche Revenue in Hematological Malignancies Business (2013-2018)
12.4.5 Roche Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hematological Malignancies Introduction
12.5.4 GlaxoSmithKline Revenue in Hematological Malignancies Business (2013-2018)
12.5.5 GlaxoSmithKline Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Company Details
12.6.2 Company Description and Business Overview
12.6.3 Hematological Malignancies Introduction
12.6.4 Johnson & Johnson Revenue in Hematological Malignancies Business (2013-2018)
12.6.5 Johnson & Johnson Recent Development
12.7 Novartis
12.7.1 Novartis Company Details
12.7.2 Company Description and Business Overview
12.7.3 Hematological Malignancies Introduction
12.7.4 Novartis Revenue in Hematological Malignancies Business (2013-2018)
12.7.5 Novartis Recent Development
12.8 Pfizer
12.8.1 Pfizer Company Details
12.8.2 Company Description and Business Overview
12.8.3 Hematological Malignancies Introduction
12.8.4 Pfizer Revenue in Hematological Malignancies Business (2013-2018)
12.8.5 Pfizer Recent Development
12.9 Teva Pharmaceutical
12.9.1 Teva Pharmaceutical Company Details
12.9.2 Company Description and Business Overview
12.9.3 Hematological Malignancies Introduction
12.9.4 Teva Pharmaceutical Revenue in Hematological Malignancies Business (2013-2018)
12.9.5 Teva Pharmaceutical Recent Development
13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Hematological Malignancies Key Market Segments
Table Key Players Hematological Malignancies Covered
Table Global Hematological Malignancies Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Hematological Malignancies Market Size Market Share by Type 2013-2025
Figure Leukemia Figures
Table Key Players of Leukemia
Figure Lymphoma Figures
Table Key Players of Lymphoma
Figure Myeloma Figures
Table Key Players of Myeloma
Table Global Hematological Malignancies Market Size Growth by Application 2013-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Medical Stores Case Studies
Figure E-commerce Platform Case Studies
Figure Hematological Malignancies Report Years Considered
Table Global Hematological Malignancies Market Size 2013-2025 (Million US$)
Figure Global Hematological Malignancies Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Hematological Malignancies Market Size by Regions 2013-2025 (Million US$)
Table Global Hematological Malignancies Market Size by Regions 2013-2018 (Million US$)
Table Global Hematological Malignancies Market Share by Regions 2013-2018
Figure Global Hematological Malignancies Market Share by Regions 2013-2018
Figure Global Hematological Malignancies Market Share by Regions 2018
Table Market Top Trends
Table Global Hematological Malignancies Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Hematological Malignancies Market Share by Manufacturers (2013-2018)
Figure Global Hematological Malignancies Market Share by Manufacturers in 2018
Table Global Hematological Malignancies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Hematological Malignancies Product/Solution/Service
Table Date of Enter into Hematological Malignancies Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Hematological Malignancies Market Size by Type (2013-2018) (Million US$)
Table Global Hematological Malignancies Market Size Share by Type (2013-2018)
Figure Global Hematological Malignancies Market Size Market Share by Type (2013-2018)
Table Global Hematological Malignancies Market Size by Application (2013-2018) (Million US$)
Table Global Hematological Malignancies Market Size Share by Application (2013-2018)
Figure Global Hematological Malignancies Market Size Market Share by Application (2013-2018)
Figure Global Hematological Malignancies Revenue Market Share by Application in 2017
Figure United States Hematological Malignancies Market Size 2013-2018 (Million US$)
Table United States Key Players Hematological Malignancies Revenue (2017-2018) (Million US$)
Table United States Key Players Hematological Malignancies Market Share (2017-2018)
Table United States Hematological Malignancies Market Size by Type (2013-2018) (Million US$)
Table United States Hematological Malignancies Market Share by Type (2013-2018)
Table United States Hematological Malignancies Market Size by Application (2013-2018) (Million US$)
Table United States Hematological Malignancies Market Share by Application (2013-2018)
Figure Europe Hematological Malignancies Market Size 2013-2018 (Million US$)
Table Europe Key Players Hematological Malignancies Revenue (2017-2018) (Million US$)
Table Europe Key Players Hematological Malignancies Market Share (2017-2018)
Table Europe Hematological Malignancies Market Size by Type (2013-2018) (Million US$)
Table Europe Hematological Malignancies Market Share by Type (2013-2018)
Table Europe Hematological Malignancies Market Size by Application (2013-2018) (Million US$)
Table Europe Hematological Malignancies Market Share by Application (2013-2018)
Figure China Hematological Malignancies Market Size 2013-2018 (Million US$)
Table China Key Players Hematological Malignancies Revenue (2017-2018) (Million US$)
Table China Key Players Hematological Malignancies Market Share (2017-2018)
Table China Hematological Malignancies Market Size by Type (2013-2018) (Million US$)
Table China Hematological Malignancies Market Share by Type (2013-2018)
Table China Hematological Malignancies Market Size by Application (2013-2018) (Million US$)
Table China Hematological Malignancies Market Share by Application (2013-2018)
Figure Japan Hematological Malignancies Market Size 2013-2018 (Million US$)
Table Japan Key Players Hematological Malignancies Revenue (2017-2018) (Million US$)
Table Japan Key Players Hematological Malignancies Market Share (2017-2018)
Table Japan Hematological Malignancies Market Size by Type (2013-2018) (Million US$)
Table Japan Hematological Malignancies Market Share by Type (2013-2018)
Table Japan Hematological Malignancies Market Size by Application (2013-2018) (Million US$)
Table Japan Hematological Malignancies Market Share by Application (2013-2018)
Figure Southeast Asia Hematological Malignancies Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Hematological Malignancies Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Hematological Malignancies Market Share (2017-2018)
Table Southeast Asia Hematological Malignancies Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Hematological Malignancies Market Share by Type (2013-2018)
Table Southeast Asia Hematological Malignancies Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Hematological Malignancies Market Share by Application (2013-2018)
Figure India Hematological Malignancies Market Size 2013-2018 (Million US$)
Table India Key Players Hematological Malignancies Revenue (2017-2018) (Million US$)
Table India Key Players Hematological Malignancies Market Share (2017-2018)
Table India Hematological Malignancies Market Size by Type (2013-2018) (Million US$)
Table India Hematological Malignancies Market Share by Type (2013-2018)
Table India Hematological Malignancies Market Size by Application (2013-2018) (Million US$)
Table India Hematological Malignancies Market Share by Application (2013-2018)
Figure Central & South America Hematological Malignancies Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Hematological Malignancies Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Hematological Malignancies Market Share (2017-2018)
Table Central & South America Hematological Malignancies Market Size by Type (2013-2018) (Million US$)
Table Central & South America Hematological Malignancies Market Share by Type (2013-2018)
Table Central & South America Hematological Malignancies Market Size by Application (2013-2018) (Million US$)
Table Central & South America Hematological Malignancies Market Share by Application (2013-2018)
Table AbbVie Company Details
Table AbbVie Revenue in Hematological Malignancies Business (2013-2018) (Million US$)
Figure AbbVie Revenue Growth Rate in Hematological Malignancies Business (2013-2018)
Table AbbVie Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Hematological Malignancies Business (2013-2018)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Hematological Malignancies Business (2013-2018)
Table Bristol-Myers Squibb Recent Development
Table Celgene Company Details
Table Celgene Revenue in Hematological Malignancies Business (2013-2018)(Million US$)
Figure Celgene Revenue Growth Rate in Hematological Malignancies Business (2013-2018)
Table Celgene Recent Development
Table Roche Company Details
Table Roche Revenue in Hematological Malignancies Business (2013-2018)(Million US$)
Figure Roche Revenue Growth Rate in Hematological Malignancies Business (2013-2018)
Table Roche Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Hematological Malignancies Business (2013-2018)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Hematological Malignancies Business (2013-2018)
Table GlaxoSmithKline Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Hematological Malignancies Business (2013-2018)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Hematological Malignancies Business (2013-2018)
Table Johnson & Johnson Recent Development
Table Novartis Company Details
Table Novartis Revenue in Hematological Malignancies Business (2013-2018)(Million US$)
Figure Novartis Revenue Growth Rate in Hematological Malignancies Business (2013-2018)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Hematological Malignancies Business (2013-2018)(Million US$)
Figure Pfizer Revenue Growth Rate in Hematological Malignancies Business (2013-2018)
Table Pfizer Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Hematological Malignancies Business (2013-2018)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Hematological Malignancies Business (2013-2018)
Table Teva Pharmaceutical Recent Development
Table Global Hematological Malignancies Market Size by Regions (Million US$) 2018-2025
Figure Global Hematological Malignancies Market Size Share by Regions (2018-2025)
Figure Global Hematological Malignancies Market Size Share by Regions in 2025
Figure United States Hematological Malignancies Market Size Forecast (2018-2025)(Million USD)
Figure Europe Hematological Malignancies Market Size Forecast (2018-2025)(Million USD)
Figure China Hematological Malignancies Market Size Forecast (2018-2025)(Million USD)
Figure Japan Hematological Malignancies Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Hematological Malignancies Market Size Forecast (2018-2025)(Million USD)
Figure India Hematological Malignancies Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Hematological Malignancies Market Size Forecast (2018-2025)(Million USD)
Table Global Hematological Malignancies Market Size by Product (2018-2025) (Million US$)
Figure Global Hematological Malignancies Market Size by Product (2018-2025)
Figure Global Hematological Malignancies Market Size by Product in 2025
Table Global Hematological Malignancies Market Size by Application (2018-2025) (Million US$)
Figure Global Hematological Malignancies Market Size by Application (2018-2025)
Figure Global Hematological Malignancies Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
